Nambling, Archie .
HRN: 22-29-47 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/10/2022
CEFUROXIME 750MG (VIAL)
12/10/2022
12/16/2022
IVT
750 Mg
Q8h
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes